Clinical Trial Update: PfSPZ Challenge in Non-immune Adults in Baltimore, USA [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of PfSPZ Challenge in non-immune adults in Baltimore has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Challenge (P. falciparum sporozoites)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection | Phase 1 | Status: COMPLETED